{"acute hepatic failure": 2.29, "adverse drug reaction": 7.45, "adverse event": 2.52, "ageusia": 2.33, "alanine aminotransferase increased": 5.04, "amylase increased": 2.62, "aspartate aminotransferase increased": 5.3, "blood albumin decreased": 2.41, "blood alkaline phosphatase increased": 3.29, "blood bilirubin increased": 8.79, "blood lactate dehydrogenase increased": 2.16, "blood pressure increased": 3.58, "blood sodium decreased": 3.18, "blood thyroid stimulating hormone increased": 9.33, "blood urine present": 3.24, "bone cancer": 8.02, "brain neoplasm": 6.79, "brain oedema": 2.34, "cardiac failure": 2.45, "cardiotoxicity": 6.99, "cholestasis": 2.83, "clear cell renal cell carcinoma": 26.96, "death": 11.25, "decreased appetite": 3.55, "dehydration": 3.13, "diarrhoea": 3.46, "disease progression": 7.79, "drug-induced liver injury": 2.87, "dry skin": 2.29, "dysgeusia": 2.09, "dysphonia": 2.16, "eating disorder": 2.2, "ejection fraction decreased": 9.6, "electrocardiogram qt prolonged": 2.17, "electrolyte imbalance": 2.53, "gamma-glutamyltransferase increased": 2.53, "gastric haemorrhage": 2.17, "gastric ulcer": 2.18, "gastrointestinal perforation": 5.89, "haemoptysis": 3.94, "hair colour changes": 113.2, "hepatic cytolysis": 4.32, "hepatic enzyme increased": 8.95, "hepatic failure": 4.88, "hepatic function abnormal": 3.48, "hepatitis": 2.88, "hepatitis acute": 2.83, "hepatotoxicity": 15.63, "hip surgery": 7.35, "hospice care": 64.01, "hospitalisation": 9.72, "hyperbilirubinaemia": 5.77, "hyperkeratosis": 4.22, "hypertension": 5.33, "hypertensive crisis": 4.2, "hypertransaminasaemia": 8.68, "hypothyroidism": 4.52, "ill-defined disorder": 3.5, "impaired healing": 3.63, "intestinal perforation": 8.51, "jaundice": 6.64, "large intestine perforation": 5.26, "left ventricular dysfunction": 2.85, "lipase increased": 2.29, "liver disorder": 2.55, "liver function test abnormal": 3.76, "liver function test increased": 7.99, "liver injury": 3.06, "malignant neoplasm progression": 9.91, "metastases to bone": 6.0, "metastases to central nervous system": 10.17, "metastases to liver": 5.9, "metastases to lung": 20.62, "metastases to lymph nodes": 5.32, "metastases to spine": 8.41, "metastasis": 14.97, "metastatic neoplasm": 10.4, "metastatic renal cell carcinoma": 28.13, "mucosal inflammation": 5.63, "neoplasm": 4.78, "neoplasm malignant": 6.04, "nephrotic syndrome": 4.13, "oral pain": 2.45, "palmar-plantar erythrodysaesthesia syndrome": 6.39, "pigmentation disorder": 4.17, "pleural effusion": 3.19, "pneumothorax": 24.93, "posterior reversible encephalopathy syndrome": 9.99, "product use in unapproved indication": 4.35, "proteinuria": 5.87, "pulmonary haemorrhage": 2.51, "pulmonary mass": 4.07, "radiotherapy": 18.4, "renal cancer": 41.28, "renal cancer metastatic": 53.39, "renal cell carcinoma": 18.46, "renal cell carcinoma stage iv": 90.85, "renal surgery": 61.65, "retinal detachment": 3.77, "retinal tear": 6.11, "sarcoma": 67.69, "sarcoma metastatic": 243.39, "second primary malignancy": 3.62, "skin discolouration": 3.1, "skin toxicity": 3.07, "skin ulcer": 2.65, "soft tissue sarcoma": 409.41, "stomatitis": 3.99, "surgery": 3.34, "taste disorder": 5.37, "transaminases increased": 6.07, "tumour excision": 43.44, "tumour haemorrhage": 6.32, "tumour pain": 26.27, "weight decreased": 3.13, "wound": 2.03, "yellow skin": 4.01}